You changed your supplier. Did you tell the FDA?

Once a product is registered with Ghana's FDA, it is easy to assume the regulatory work is finished and the business can simply run — change a supplier when a better one appears, adjust a pack size for a new distributor, update a formulation to cut cost. Many companies make exactly these changes quietly, without realising that a registered product is not a fixed asset you can alter freely. It is an approval tied to a specific, documented set of facts.

Why variations exist

Ghana FDA's evaluation and approval are based on the dossier as submitted — a specific manufacturing site, a specific formulation, specific stability data, specific labelling. When any of that changes after approval, the product on the market may no longer match what was actually evaluated. A variation is the mechanism for keeping the registration accurate: notifying, and in many cases seeking approval from, the FDA before a change takes effect.

What commonly triggers a variation

• A new or additional manufacturing site — including contract manufacturing arrangements
• Formulation or raw-material supplier changes
• Updated shelf life or storage conditions
• Revised labelling, artwork or pack sizes

Not every change carries equal regulatory weight. Some variations require prior FDA approval before implementation; others require notification without necessarily halting the change. The category a specific change falls into determines the process — and getting that classification wrong, either by over-filing minor administrative updates or under-filing a substantive change, creates its own friction with the Authority.

Building variations into how you operate

The companies that handle this well are the ones who treat "does this need a variation filing" as a standing question whenever a supplier, process or packaging decision is being made — not something that gets asked after the change is already in effect. That single habit prevents most of the exposure this creates.

Samuel E.K. AgyeiB.Pharm, MPSGHManaging Director & Licensed Pharmacist, SCS Pharma Consult — Ghana FDA regulatory affairs, GMP compliance and pharmaceutical market entry.